MTARC1 and liver disorder: Several recent reports have highlighted the role of mARC1 in rodent models of liver disease, demonstrating that the loss of mARC1 by siRNA knockdown can reduce liver triglycerides and decrease circulating ALT and cholesterol levels28, 29, 30 which is consistent with human genetics.